Melatonin delivery from PCL scaffold enhances glycosaminoglycans deposition in human chondrocytes – Bioactive scaffold model for cartilage regeneration

[Display omitted] •Melatonin albumin nanoparticle (MNP) embedded polycaprolactone scaffold fabricated.•Controlled release observed for 22 days.•MNP concentration modulated melatonin release from scaffolds.•Significant elevation in Glycosaminoglycans - Human chondrocytes.•Diffusion & dissolution...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Process biochemistry (1991) 2020-12, Vol.99, p.36-47
Hauptverfasser: S., Manjunath Kamath, Rao, Subha Krishna, D., Jaison, K., Sridhar, N., Kasthuri, V., Gopinath, P., Sivaperumal, S., Shantanu Patil
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 47
container_issue
container_start_page 36
container_title Process biochemistry (1991)
container_volume 99
creator S., Manjunath Kamath
Rao, Subha Krishna
D., Jaison
K., Sridhar
N., Kasthuri
V., Gopinath
P., Sivaperumal
S., Shantanu Patil
description [Display omitted] •Melatonin albumin nanoparticle (MNP) embedded polycaprolactone scaffold fabricated.•Controlled release observed for 22 days.•MNP concentration modulated melatonin release from scaffolds.•Significant elevation in Glycosaminoglycans - Human chondrocytes.•Diffusion & dissolution mechanism of drug release – mathematical models. The therapeutic potential of an engineered cartilage construct can be enhanced by sustained delivery of chondrogenic drug like melatonin from 3D porous scaffolds embedded with melatonin loaded bovine serum albumin nanoparticles (MNP). In this study, MNP was synthesized and loaded into polycaprolactone (PCL) scaffolds. 12 % (w/v) and 10 % (w/v) PCL scaffolds were fabricated with different concentrations of MNP. X- ray diffraction and Raman analysis of MNP and scaffolds revealed amorphization of melatonin which is highly desired in drug delivery applications. Additionally, Fourier Transform Infrared spectroscopic analysis confirmed the drug to be chemically inert to fabrication process. Field emission scanning electron microscopic analysis suggested highly interlinked porous scaffold (diameter 50 μm – 300 μm) and MNP diameters in the range of 110−200 nm. Importantly, UV spectrophotometric analysis showed that all groups of scaffolds showed sustained release for 21 days, wherein MNP concentration had an influence on release behaviour of melatonin from scaffolds. Drug release kinetics studied using mathematical models revealed, diffusion and dissolution mechanism of release. Furthermore, in vitro evaluation of MNP loaded scaffolds with Human chondrocytes for 21 days increased glycosaminoglycans deposition significantly. In brief, sustained release of melatonin from polycaprolactone scaffolds increased the therapeutic potential of the engineered construct.
doi_str_mv 10.1016/j.procbio.2020.08.015
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2478256681</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1359511320309855</els_id><sourcerecordid>2478256681</sourcerecordid><originalsourceid>FETCH-LOGICAL-c337t-50e7e79ad898efd5beac33b84c0151f4cc00e7a289c6d61274d7a5f8779b7d743</originalsourceid><addsrcrecordid>eNqFkctKLDEURQtR8PkJQsBxlUm9khqJNj4u9OU60HFIJyfdaaqSNqkWeuY_OPL3_BJP0w0O7ygHsvc6j51ll4wWjLL2elmsYtAzF4qSlrSgoqCsOchOmOBVXpWdOMS6arq8Yaw6zk5TWlJaMcboSfb1F3o1Bu88MdC7d4gbYmMYyPNkSpJW1obeEPAL5TUkMu83OiQ1OB-2pfIJbauQ3OiCJwhZrAfliV4Eb3CmzYie749PcueC0iPif5lDwIbEhki0iqPr1RxIhDl4iGpLO8-OrOoTXOzfs-z14f5l8pRP_z3-mdxOc11VfMwbChx4p4zoBFjTzEDhx0zUGo_AbK01RYUqRadb07KS14arxgrOuxk3vK7OsqsdF4_4toY0ymVYR48tZVlzUTZtKxiqmp1Kx5BSBCtX0Q0qbiSjcpuCXMp9CnKbgqRC4gDou9n5AFd4dxBl0g7wlsZF0KM0wf2H8ANNG5h7</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2478256681</pqid></control><display><type>article</type><title>Melatonin delivery from PCL scaffold enhances glycosaminoglycans deposition in human chondrocytes – Bioactive scaffold model for cartilage regeneration</title><source>Access via ScienceDirect (Elsevier)</source><creator>S., Manjunath Kamath ; Rao, Subha Krishna ; D., Jaison ; K., Sridhar ; N., Kasthuri ; V., Gopinath ; P., Sivaperumal ; S., Shantanu Patil</creator><creatorcontrib>S., Manjunath Kamath ; Rao, Subha Krishna ; D., Jaison ; K., Sridhar ; N., Kasthuri ; V., Gopinath ; P., Sivaperumal ; S., Shantanu Patil</creatorcontrib><description>[Display omitted] •Melatonin albumin nanoparticle (MNP) embedded polycaprolactone scaffold fabricated.•Controlled release observed for 22 days.•MNP concentration modulated melatonin release from scaffolds.•Significant elevation in Glycosaminoglycans - Human chondrocytes.•Diffusion &amp; dissolution mechanism of drug release – mathematical models. The therapeutic potential of an engineered cartilage construct can be enhanced by sustained delivery of chondrogenic drug like melatonin from 3D porous scaffolds embedded with melatonin loaded bovine serum albumin nanoparticles (MNP). In this study, MNP was synthesized and loaded into polycaprolactone (PCL) scaffolds. 12 % (w/v) and 10 % (w/v) PCL scaffolds were fabricated with different concentrations of MNP. X- ray diffraction and Raman analysis of MNP and scaffolds revealed amorphization of melatonin which is highly desired in drug delivery applications. Additionally, Fourier Transform Infrared spectroscopic analysis confirmed the drug to be chemically inert to fabrication process. Field emission scanning electron microscopic analysis suggested highly interlinked porous scaffold (diameter 50 μm – 300 μm) and MNP diameters in the range of 110−200 nm. Importantly, UV spectrophotometric analysis showed that all groups of scaffolds showed sustained release for 21 days, wherein MNP concentration had an influence on release behaviour of melatonin from scaffolds. Drug release kinetics studied using mathematical models revealed, diffusion and dissolution mechanism of release. Furthermore, in vitro evaluation of MNP loaded scaffolds with Human chondrocytes for 21 days increased glycosaminoglycans deposition significantly. In brief, sustained release of melatonin from polycaprolactone scaffolds increased the therapeutic potential of the engineered construct.</description><identifier>ISSN: 1359-5113</identifier><identifier>EISSN: 1873-3298</identifier><identifier>DOI: 10.1016/j.procbio.2020.08.015</identifier><language>eng</language><publisher>Barking: Elsevier Ltd</publisher><subject>Amorphization ; Bovine serum albumin ; Cartilage ; Chondrocyte ; Chondrocytes ; Construction engineering ; Controlled release ; Deposition ; Drug delivery ; Drug release ; Emission analysis ; Fabrication ; Field emission microscopy ; Fourier analysis ; Fourier transforms ; Glycosaminoglycans ; Infrared analysis ; Mathematical models ; Melatonin ; Microscopic analysis ; Nanoparticles ; Polycaprolactone ; Porous scaffolds ; Raman spectroscopy ; Regeneration ; Scaffolds ; Scanning electron microscopy ; Serum albumin ; Spectrophotometry ; Sustained release</subject><ispartof>Process biochemistry (1991), 2020-12, Vol.99, p.36-47</ispartof><rights>2020 Elsevier Ltd</rights><rights>Copyright Elsevier BV Dec 2020</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c337t-50e7e79ad898efd5beac33b84c0151f4cc00e7a289c6d61274d7a5f8779b7d743</citedby><cites>FETCH-LOGICAL-c337t-50e7e79ad898efd5beac33b84c0151f4cc00e7a289c6d61274d7a5f8779b7d743</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.procbio.2020.08.015$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>315,781,785,3551,27926,27927,45997</link.rule.ids></links><search><creatorcontrib>S., Manjunath Kamath</creatorcontrib><creatorcontrib>Rao, Subha Krishna</creatorcontrib><creatorcontrib>D., Jaison</creatorcontrib><creatorcontrib>K., Sridhar</creatorcontrib><creatorcontrib>N., Kasthuri</creatorcontrib><creatorcontrib>V., Gopinath</creatorcontrib><creatorcontrib>P., Sivaperumal</creatorcontrib><creatorcontrib>S., Shantanu Patil</creatorcontrib><title>Melatonin delivery from PCL scaffold enhances glycosaminoglycans deposition in human chondrocytes – Bioactive scaffold model for cartilage regeneration</title><title>Process biochemistry (1991)</title><description>[Display omitted] •Melatonin albumin nanoparticle (MNP) embedded polycaprolactone scaffold fabricated.•Controlled release observed for 22 days.•MNP concentration modulated melatonin release from scaffolds.•Significant elevation in Glycosaminoglycans - Human chondrocytes.•Diffusion &amp; dissolution mechanism of drug release – mathematical models. The therapeutic potential of an engineered cartilage construct can be enhanced by sustained delivery of chondrogenic drug like melatonin from 3D porous scaffolds embedded with melatonin loaded bovine serum albumin nanoparticles (MNP). In this study, MNP was synthesized and loaded into polycaprolactone (PCL) scaffolds. 12 % (w/v) and 10 % (w/v) PCL scaffolds were fabricated with different concentrations of MNP. X- ray diffraction and Raman analysis of MNP and scaffolds revealed amorphization of melatonin which is highly desired in drug delivery applications. Additionally, Fourier Transform Infrared spectroscopic analysis confirmed the drug to be chemically inert to fabrication process. Field emission scanning electron microscopic analysis suggested highly interlinked porous scaffold (diameter 50 μm – 300 μm) and MNP diameters in the range of 110−200 nm. Importantly, UV spectrophotometric analysis showed that all groups of scaffolds showed sustained release for 21 days, wherein MNP concentration had an influence on release behaviour of melatonin from scaffolds. Drug release kinetics studied using mathematical models revealed, diffusion and dissolution mechanism of release. Furthermore, in vitro evaluation of MNP loaded scaffolds with Human chondrocytes for 21 days increased glycosaminoglycans deposition significantly. In brief, sustained release of melatonin from polycaprolactone scaffolds increased the therapeutic potential of the engineered construct.</description><subject>Amorphization</subject><subject>Bovine serum albumin</subject><subject>Cartilage</subject><subject>Chondrocyte</subject><subject>Chondrocytes</subject><subject>Construction engineering</subject><subject>Controlled release</subject><subject>Deposition</subject><subject>Drug delivery</subject><subject>Drug release</subject><subject>Emission analysis</subject><subject>Fabrication</subject><subject>Field emission microscopy</subject><subject>Fourier analysis</subject><subject>Fourier transforms</subject><subject>Glycosaminoglycans</subject><subject>Infrared analysis</subject><subject>Mathematical models</subject><subject>Melatonin</subject><subject>Microscopic analysis</subject><subject>Nanoparticles</subject><subject>Polycaprolactone</subject><subject>Porous scaffolds</subject><subject>Raman spectroscopy</subject><subject>Regeneration</subject><subject>Scaffolds</subject><subject>Scanning electron microscopy</subject><subject>Serum albumin</subject><subject>Spectrophotometry</subject><subject>Sustained release</subject><issn>1359-5113</issn><issn>1873-3298</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNqFkctKLDEURQtR8PkJQsBxlUm9khqJNj4u9OU60HFIJyfdaaqSNqkWeuY_OPL3_BJP0w0O7ygHsvc6j51ll4wWjLL2elmsYtAzF4qSlrSgoqCsOchOmOBVXpWdOMS6arq8Yaw6zk5TWlJaMcboSfb1F3o1Bu88MdC7d4gbYmMYyPNkSpJW1obeEPAL5TUkMu83OiQ1OB-2pfIJbauQ3OiCJwhZrAfliV4Eb3CmzYie749PcueC0iPif5lDwIbEhki0iqPr1RxIhDl4iGpLO8-OrOoTXOzfs-z14f5l8pRP_z3-mdxOc11VfMwbChx4p4zoBFjTzEDhx0zUGo_AbK01RYUqRadb07KS14arxgrOuxk3vK7OsqsdF4_4toY0ymVYR48tZVlzUTZtKxiqmp1Kx5BSBCtX0Q0qbiSjcpuCXMp9CnKbgqRC4gDou9n5AFd4dxBl0g7wlsZF0KM0wf2H8ANNG5h7</recordid><startdate>202012</startdate><enddate>202012</enddate><creator>S., Manjunath Kamath</creator><creator>Rao, Subha Krishna</creator><creator>D., Jaison</creator><creator>K., Sridhar</creator><creator>N., Kasthuri</creator><creator>V., Gopinath</creator><creator>P., Sivaperumal</creator><creator>S., Shantanu Patil</creator><general>Elsevier Ltd</general><general>Elsevier BV</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7QO</scope><scope>7T7</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>M7N</scope><scope>P64</scope></search><sort><creationdate>202012</creationdate><title>Melatonin delivery from PCL scaffold enhances glycosaminoglycans deposition in human chondrocytes – Bioactive scaffold model for cartilage regeneration</title><author>S., Manjunath Kamath ; Rao, Subha Krishna ; D., Jaison ; K., Sridhar ; N., Kasthuri ; V., Gopinath ; P., Sivaperumal ; S., Shantanu Patil</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c337t-50e7e79ad898efd5beac33b84c0151f4cc00e7a289c6d61274d7a5f8779b7d743</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Amorphization</topic><topic>Bovine serum albumin</topic><topic>Cartilage</topic><topic>Chondrocyte</topic><topic>Chondrocytes</topic><topic>Construction engineering</topic><topic>Controlled release</topic><topic>Deposition</topic><topic>Drug delivery</topic><topic>Drug release</topic><topic>Emission analysis</topic><topic>Fabrication</topic><topic>Field emission microscopy</topic><topic>Fourier analysis</topic><topic>Fourier transforms</topic><topic>Glycosaminoglycans</topic><topic>Infrared analysis</topic><topic>Mathematical models</topic><topic>Melatonin</topic><topic>Microscopic analysis</topic><topic>Nanoparticles</topic><topic>Polycaprolactone</topic><topic>Porous scaffolds</topic><topic>Raman spectroscopy</topic><topic>Regeneration</topic><topic>Scaffolds</topic><topic>Scanning electron microscopy</topic><topic>Serum albumin</topic><topic>Spectrophotometry</topic><topic>Sustained release</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>S., Manjunath Kamath</creatorcontrib><creatorcontrib>Rao, Subha Krishna</creatorcontrib><creatorcontrib>D., Jaison</creatorcontrib><creatorcontrib>K., Sridhar</creatorcontrib><creatorcontrib>N., Kasthuri</creatorcontrib><creatorcontrib>V., Gopinath</creatorcontrib><creatorcontrib>P., Sivaperumal</creatorcontrib><creatorcontrib>S., Shantanu Patil</creatorcontrib><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Process biochemistry (1991)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>S., Manjunath Kamath</au><au>Rao, Subha Krishna</au><au>D., Jaison</au><au>K., Sridhar</au><au>N., Kasthuri</au><au>V., Gopinath</au><au>P., Sivaperumal</au><au>S., Shantanu Patil</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Melatonin delivery from PCL scaffold enhances glycosaminoglycans deposition in human chondrocytes – Bioactive scaffold model for cartilage regeneration</atitle><jtitle>Process biochemistry (1991)</jtitle><date>2020-12</date><risdate>2020</risdate><volume>99</volume><spage>36</spage><epage>47</epage><pages>36-47</pages><issn>1359-5113</issn><eissn>1873-3298</eissn><abstract>[Display omitted] •Melatonin albumin nanoparticle (MNP) embedded polycaprolactone scaffold fabricated.•Controlled release observed for 22 days.•MNP concentration modulated melatonin release from scaffolds.•Significant elevation in Glycosaminoglycans - Human chondrocytes.•Diffusion &amp; dissolution mechanism of drug release – mathematical models. The therapeutic potential of an engineered cartilage construct can be enhanced by sustained delivery of chondrogenic drug like melatonin from 3D porous scaffolds embedded with melatonin loaded bovine serum albumin nanoparticles (MNP). In this study, MNP was synthesized and loaded into polycaprolactone (PCL) scaffolds. 12 % (w/v) and 10 % (w/v) PCL scaffolds were fabricated with different concentrations of MNP. X- ray diffraction and Raman analysis of MNP and scaffolds revealed amorphization of melatonin which is highly desired in drug delivery applications. Additionally, Fourier Transform Infrared spectroscopic analysis confirmed the drug to be chemically inert to fabrication process. Field emission scanning electron microscopic analysis suggested highly interlinked porous scaffold (diameter 50 μm – 300 μm) and MNP diameters in the range of 110−200 nm. Importantly, UV spectrophotometric analysis showed that all groups of scaffolds showed sustained release for 21 days, wherein MNP concentration had an influence on release behaviour of melatonin from scaffolds. Drug release kinetics studied using mathematical models revealed, diffusion and dissolution mechanism of release. Furthermore, in vitro evaluation of MNP loaded scaffolds with Human chondrocytes for 21 days increased glycosaminoglycans deposition significantly. In brief, sustained release of melatonin from polycaprolactone scaffolds increased the therapeutic potential of the engineered construct.</abstract><cop>Barking</cop><pub>Elsevier Ltd</pub><doi>10.1016/j.procbio.2020.08.015</doi><tpages>12</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1359-5113
ispartof Process biochemistry (1991), 2020-12, Vol.99, p.36-47
issn 1359-5113
1873-3298
language eng
recordid cdi_proquest_journals_2478256681
source Access via ScienceDirect (Elsevier)
subjects Amorphization
Bovine serum albumin
Cartilage
Chondrocyte
Chondrocytes
Construction engineering
Controlled release
Deposition
Drug delivery
Drug release
Emission analysis
Fabrication
Field emission microscopy
Fourier analysis
Fourier transforms
Glycosaminoglycans
Infrared analysis
Mathematical models
Melatonin
Microscopic analysis
Nanoparticles
Polycaprolactone
Porous scaffolds
Raman spectroscopy
Regeneration
Scaffolds
Scanning electron microscopy
Serum albumin
Spectrophotometry
Sustained release
title Melatonin delivery from PCL scaffold enhances glycosaminoglycans deposition in human chondrocytes – Bioactive scaffold model for cartilage regeneration
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-18T11%3A44%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Melatonin%20delivery%20from%20PCL%20scaffold%20enhances%20glycosaminoglycans%20deposition%20in%20human%20chondrocytes%20%E2%80%93%20Bioactive%20scaffold%20model%20for%20cartilage%20regeneration&rft.jtitle=Process%20biochemistry%20(1991)&rft.au=S.,%20Manjunath%20Kamath&rft.date=2020-12&rft.volume=99&rft.spage=36&rft.epage=47&rft.pages=36-47&rft.issn=1359-5113&rft.eissn=1873-3298&rft_id=info:doi/10.1016/j.procbio.2020.08.015&rft_dat=%3Cproquest_cross%3E2478256681%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2478256681&rft_id=info:pmid/&rft_els_id=S1359511320309855&rfr_iscdi=true